DK608089A - Antiviralt middel - Google Patents

Antiviralt middel Download PDF

Info

Publication number
DK608089A
DK608089A DK608089A DK608089A DK608089A DK 608089 A DK608089 A DK 608089A DK 608089 A DK608089 A DK 608089A DK 608089 A DK608089 A DK 608089A DK 608089 A DK608089 A DK 608089A
Authority
DK
Denmark
Prior art keywords
rna
bioparyl
flavopereirine
primers
fragments
Prior art date
Application number
DK608089A
Other languages
English (en)
Other versions
DK608089D0 (da
Inventor
Mirko Beljanski
Original Assignee
Fondation Encourag Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fondation Encourag Rech Med filed Critical Fondation Encourag Rech Med
Publication of DK608089D0 publication Critical patent/DK608089D0/da
Publication of DK608089A publication Critical patent/DK608089A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Communicable Diseases (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK608089A 1988-12-02 1989-12-01 Antiviralt middel DK608089A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8815845A FR2639830B1 (fr) 1988-12-02 1988-12-02 Composition antivirale et ses applications

Publications (2)

Publication Number Publication Date
DK608089D0 DK608089D0 (da) 1989-12-01
DK608089A true DK608089A (da) 1990-06-03

Family

ID=9372531

Family Applications (1)

Application Number Title Priority Date Filing Date
DK608089A DK608089A (da) 1988-12-02 1989-12-01 Antiviralt middel

Country Status (8)

Country Link
EP (1) EP0373986B1 (da)
JP (1) JPH0737393B2 (da)
AT (1) ATE94072T1 (da)
DE (1) DE68909019T2 (da)
DK (1) DK608089A (da)
ES (1) ES2059803T3 (da)
FR (1) FR2639830B1 (da)
IL (1) IL92523A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02270824A (ja) * 1989-04-13 1990-11-05 Snow Brand Milk Prod Co Ltd 逆転写酵素阻害剤
DE4105570A1 (de) * 1991-02-22 1992-08-27 Helmut Dr Med Scholle Verwendung eines bakterien- und eiweissfreien filtrats
DE4208868A1 (de) * 1992-03-04 1993-09-09 Michaelis Peter Dr Med Verwendung eines arzneimittels zur behandlung von metastatischen krebserkrankungen
FR2694693B1 (fr) * 1992-07-28 1994-10-28 Abrax Bio Labs Sa Composition pharmaceutique à base de flavopéréirine et son utilisation dans un traitement contre le virus VIH.
DE4308443C2 (de) * 1993-03-17 1996-09-19 Laves Hans Georg Arzneimittel zur Behandlung von Retrovirusinfektionen
JP2003504327A (ja) * 1999-07-08 2003-02-04 プレンダーガスト、パトリック、ティ． 感染症の治療を目的としたフラボン類、クマリン類および関連化合物の使用
KR100417172B1 (ko) * 2000-08-04 2004-02-05 주식회사 안지오랩 은행엽 엑스를 유효성분으로 하는 혈관신생 억제제
CN101027070B (zh) * 2004-05-19 2012-08-08 自然来源国际公司 治疗和预防前列腺癌中的黄佩瑞任和鸡骨常山碱组合
CN107501224B (zh) * 2017-09-12 2021-01-19 临沂金卓生物科技有限公司 一种沸石分子筛催化水解银杏黄酮糖苷生产黄酮苷元的方法
EP3773582B1 (en) 2018-03-31 2023-10-25 Molecular International Research, Inc. Selective anti-cancer agent effective for prevention and treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450607A2 (fr) * 1978-03-13 1980-10-03 Beljanski Mirko Composition pharmaceutique contenant comme principe actif la flavopereine
DE3172570D1 (en) * 1981-03-11 1985-11-14 Mirko Beljanski Serpentine, alstonine and sempervirine drugs for the specific inhibition of tumurous and cancerous cells

Also Published As

Publication number Publication date
DK608089D0 (da) 1989-12-01
DE68909019T2 (de) 1994-03-17
DE68909019D1 (de) 1993-10-14
IL92523A0 (en) 1990-08-31
FR2639830B1 (fr) 1991-03-22
EP0373986B1 (fr) 1993-09-08
JPH0737393B2 (ja) 1995-04-26
EP0373986A1 (fr) 1990-06-20
IL92523A (en) 1994-05-30
FR2639830A1 (fr) 1990-06-08
ES2059803T3 (es) 1994-11-16
JPH02184632A (ja) 1990-07-19
ATE94072T1 (de) 1993-09-15

Similar Documents

Publication Publication Date Title
ES2070981T3 (es) Concentrados de componente activo y nuevas combinaciones de componente activo de hojas de ginkgo biloba, sus metodos de preparacion y productos farmaceuticos que contienen los concentrados de componente activo o las combinaciones de componente activo.
AU591125B2 (en) Therapeutic nucleosides
PT88930A (pt) Processo para a preparacao de novos analogos de nucleosidos e de composicoes farmaceuticas que os contem
AU1331588A (en) Method for treatment of alcohol abuse
DZ1227A1 (fr) Dérivés de benzopyrane procédé pour leur préparation et médicaments contenant les dits dérivés.
ATE233250T1 (de) Saccharinderivate als proteolytische enzyminhibitoren
DK608089A (da) Antiviralt middel
DE3767839D1 (de) Pyrrolidinamid-derivate mit antipropylendopeptidase-wirkung, zusammenstellungen, die sie enthalten, verfahren zu ihrer herstellung und heilmittel, die sie enthalten.
DE68929388T2 (de) Aus Harn isolierte antikoagulierende Verbindung
ES2045182T3 (es) Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
ATE74768T1 (de) Feste pharmazeutische zubereitung und verfahren zur herstellung derselben.
ATE77239T1 (de) Zubereitung zur stimulation der chondrozyten und des osteoblastes (ossein-hydroxyapatitverbindung), verfahren zur herstellung und pharmazeutische produkten, die sie enthalten.
DE3887068D1 (de) 2,2-Dimethylchromenderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
WO1990013281A3 (en) Method of suppressing hiv infection
DE68927055D1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ATE102623T1 (de) Theophyllinmethyldithiolan und theophyllinmethyldithianylderivate, ein verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
OA08165A (fr) Nouveaux dérivés thiosulfonates, leur procédé de préparation ainsi que les compositions pharmaceutiques les contenant.
DK113789D0 (da) Thiosulfinsyrederivater, deres anvendelse til behandling af betaendelsessygdomme samt laegemiddel indeholdende disse stoffer
FR2595697B1 (fr) Derives de benzyl-pyrimidine, leur procede de preparation ainsi que les compositions en contenant
DE3769358D1 (de) 1-acyl-2,3-dihydro-4(1h)-chinolinon-4-oxim-derivate, verfahren zur herstellung davon, pharmazeutische zusammensetzungen und zwischenprodukte.
PT90169A (pt) Processo para a preparacao de composicoes farmaceuticas contendo timopentina para o tratamento de pacientes sofrendo de viremias provocadas por hiv
FR2617481B1 (fr) Nouveaux derives de la tetrahydropyridine, leur procede de preparation et les intermediaires de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant
FR2544313B1 (fr) Les n-cycloalcoyl methyl-2 oxo-3 diaryl 5-6 as triazines, leur procede de fabrication et leur utilisation en tant que medicament
EP0253650A3 (en) Improvements relating to benzothiophene derivatives
DK0950053T3 (da) Hidtil ukendte benzoylalkyl.1,2,3,6-tetrahydropyridinderivater

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment